Guidelines International Network | Guidelines International Network (GIN)

Unruptierte intrakranielle Aneurysmen. S3-LL (DGN)

MeSH Terms: Intracranial Aneurysm (C14.907.253.560.300); Intracranial Aneurysm (C10.228.140.300.510.600); Intracranial Aneurysm (C14.907.055.635)
Guideline Contact: Ina Kopp ([email protected])
English Title Translation: Undisruptive intracranial aneurysms
Expected Publication Date: 30/06/2025
Publication Scope: assessment; management
Countries of Application: Germany
Guideline Publication Status: Development
Languages: German
Authors: AWMF (DE)

Update of the Australian Guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder

MeSH Terms: Stress Disorders; Traumatic (F03.080.931)
Guideline Contact: Skye Newton ([email protected])
Expected Publication Date: 31/12/2013
Publication Scope: management
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: AHTA (AU)
Publication Year: 2013

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

MeSH Terms: Adenocarcinoma of Lung (C04.557.470.200.025.022); Carcinoma, Non-Small-Cell Lung (C04.588.894.797.520.109.220.249); Lung neoplasms (C04.588.894.797.520); Carcinoma, Bronchogenic (C04.588.894.797.520.109.220); "Genes, erbB-1" (G05.360.340.024.340.375.500.791.295.300); "ErbB Receptors" (D08.811.913.696.620.682.725.400.009); "Proto-Oncogene proteins p21(ras)" (D08.811.277.040.330.300.400.500.600); "Anaplastic lymphoma kinase” (D08.811.913.696.620.682.725.400.002); "Proto-oncogene proteins" (D12.776.624.664.700); "Proto-oncogene proteins B-raf" (D08.811.913.696.620.682.700.559.842.374); "Receptor, trkA" (D08.811.913.696.620.682.725.400.660); "Receptor, trkB" (D08.811.913.696.620.682.725.400.700); "Receptor, trkC" (D08.811.913.696.620.682.725.400.800); "Proto-oncogene proteins c-met" (D08.811.913.696.620.682.725.400.075); "Proto-oncogene proteins c-ret" (D08.811.913.696.620.682.725.400.087); Receptor, ErbB-2 (D08.811.913.696.620.682.725.400.009.400); Proto-oncogene proteins c-akt (D08.811.913.696.620.682.700.755); Discoidin Domain Receptor 2 (D08.811.913.696.620.682.725.400.005.750); Receptor, Fibroblast growth factor, type 1 (D08.811.913.696.620.682.725.400.177); Receptor, Fibroblast growth factor, type 2 (D08.811.913.696.620.682.725.400.178); Receptor, Fibroblast growth factor, type 3 (D08.811.913.696.620.682.725.400.179); Receptor, Fibroblast growth factor, type 4 (D08.811.913.696.620.682.725.400.180); "Kelch-like ECH-associated protein 1" (D12.644.360.024.306); "MAP Kinase Kinase 1" (D08.811.913.696.620.682.700.565.100); Neuregulin-1 (D12.644.276.860.550.750); Class I Phosphatidylinositol 3-Kinases (D08.811.913.696.620.500.100.100); Tumor suppressor protein p53 (D12.776.157.687.650)
Guideline Contact: Christina Ventura ([email protected])
Keywords: tki, molecular testing, treatment, lung cancer patients, targeted tyrosine kinase inhibitors, cap, college of american pathologists, international association for the study of lung cancer, association for molecular pathology, guideline update, evidence-based guideline, clinical molecular testing of non-small cell lung cancers, nsclc
Publication Date: Original Published: June 2013 Update Published: January 22, 2018
Expected Publication Date: Update: Q4, 2025
Publication Scope: assessment
Countries of Application: United States
Guideline Publication Status: Under Review
Languages: English
Authors: CAP (US)
Publication Year: 2018

Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services

MeSH Terms: Sexually Transmitted Diseases; Syphilis; Treponema pallidum; Chlamydia trachomatis; Chlamydia Infections; Neisseria gonorrhoeae; HIV Infections; Self-Testing; Drug Therapy; Pregnancy; Community Health Services; Guideline
Guideline Contact: [email protected]
English Title Translation: Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services
Countries of Application: Global
Guideline Publication Status: Published
Languages: English
Authors: World Health Organization
Publication Year: 15/07/2024

Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring: March 2021

MeSH Terms: Guideline; HIV Infections; Anti-Retroviral Agents; Clinical Medicine
Guideline Contact: [email protected]
English Title Translation: Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
Countries of Application: Global
Guideline Publication Status: Published
Languages: English
Authors: World Health Organization
Publication Year: 17/03/2021

Updated recommendations on service delivery for the treatment and care of people living with HIV

MeSH Terms: Antiretroviral Therapy, Highly Active; HIV; Delivery of Health Care; HIV Infections; Guideline; Anti-Retroviral Agents
Guideline Contact: [email protected]
English Title Translation: Updated recommendations on service delivery for the treatment and care of people living with HIV
Countries of Application: Global
Guideline Publication Status: Published
Languages: English
Authors: World Health Organization
Publication Year: 30/04/2021

Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics

MeSH Terms: Hepatitis C; Liver Diseases; Guideline; Patient Care; Adolescent; Child; Decision Making; Hepatitis C, Chronic
Guideline Contact: [email protected]
English Title Translation: Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics
Countries of Application: Global
Guideline Publication Status: Published
Languages: English
Authors: World Health Organization
Publication Year: 18/10/2022

Updating the Canadian Clinical Practice Guideline for Managing Pediatric Obesity: A Protocol

MeSH Terms: Pediatric Obesity (D063766); Disease Management (D019468); Systematic Review (D000078182); Practice Guideline (D017065); Canada (D002170)
Guideline Contact: Geoff Ball ([email protected])
Keywords: Obesity; Pediatric; Guideline; Systematic Review; Canada
Expected Publication Date: 31.1.2025
Date of Last Evidence Search: 15-Sep-20
Methods Applied: Systematic Review; Scoping Review; Environmental Scan; GRADE; PRIMSA-ScR; AGREE II
Publication Scope: assessment; management
Countries of Application: Canada
Guideline Publication Status: Development
Languages: English; French
Authors: Johnston et al
Willingness to Collaborate: Yes
Name of Endorsing Organization: Obesity Canada

- My Saved Lists

Upgrade der S2k-Leitlinie Indikationen für die radiologische 3D Diagnostik und navigierte Implantatinsertion. S3-LL (DGZMK, DGI)

MeSH Terms
Guideline Contact: Ina Kopp ([email protected])
English Title Translation: Upgrade of the S2k guideline indications for radiological 3D diagnostics and navigated implant insertion
Expected Publication Date: 31/12/2026
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Development
Languages: German
Authors: AWMF (DE)

Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians

MeSH Terms: Risk Factors (E05.318.740.600.800.725); Unnecessary Procedures (N02.421.380.900); Unnecessary Procedures (N05.300.150.395.900); Adenocarcinoma (C04.557.470.200.025); Barrett Esophagus (C06.198.102); Barrett Esophagus (C06.405.117.102); Chronic Disease (C23.550.291.500); Endoscopy; Gastrointestinal (E04.210.240.250); Endoscopy; Gastrointestinal (E01.370.372.250.250); Endoscopy; Gastrointestinal (E01.370.388.250.250.250); Endoscopy; Gastrointestinal (E04.502.250.250.250); Esophageal Neoplasms (C04.588.443.353); Esophageal Neoplasms (C04.588.274.476.205); Esophageal Neoplasms (C06.405.117.430); Esophageal Neoplasms (C06.405.249.205); Esophageal Neoplasms (C06.301.371.205); Gastroesophageal Reflux (C06.405.117.119.500.484); Middle Aged (M01.060.116.630); Precancerous Conditions (C04.834); Proton Pump Inhibitors (D27.505.519.389.848)
Guideline Contact: Amir Qaseem ([email protected])
Publication Scope: assessment; management
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ACP (US)
Publication Year: 2012